Page last updated: 2024-10-31

nadifloxacin and Gram-Positive Bacterial Infections

nadifloxacin has been researched along with Gram-Positive Bacterial Infections in 2 studies

nadifloxacin: (R)-isomer does not induce chromosomal aberrations, unlike (S)-isomer; structure given in first source

Gram-Positive Bacterial Infections: Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.

Research Excerpts

ExcerptRelevanceReference
"Nadifloxacin was active against all aerobic and anaerobic isolates."1.32Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections. ( Haustein, UF; Hittel, N; Nenoff, P, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nenoff, P1
Haustein, UF1
Hittel, N1
Komagata, Y1
Komiyama, K1
Nomura, S1

Other Studies

2 other studies available for nadifloxacin and Gram-Positive Bacterial Infections

ArticleYear
Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
    Chemotherapy, 2004, Volume: 50, Issue:4

    Topics: Administration, Topical; Bacteria, Aerobic; Bacteria, Anaerobic; DNA Damage; Fluoroquinolones; Gram-

2004
[Fundamental studies on antibacterial activity of clindamycin against Propionibacterium acnes].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:2

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Dose-Re

1998